← Back to Search

Prednisone for Vasectomy Reversal Outcomes

Phase 4
Waitlist Available
Research Sponsored by Charitable Union for the Research and Education of Peyronie's Disease
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-65 years of age
Men undergoing a first-time vasectomy reversal at the Male Fertility and Peyronie's Clinic
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This trial looks at the effects of prednisone on sperm parameters and pregnancy rates after a vasectomy reversal. It also assesses any adverse effects of using prednisone.

Who is the study for?
This trial is for men aged 18-65 who want to restore fertility after a vasectomy, have previously fathered a child, and are undergoing their first vasectomy reversal. Their partner must be under 36 with no known fertility issues and not on birth control recently. Men can't join if they've had chemotherapy, testosterone use within the last year, kidney problems, diabetes, high blood pressure or only one testicle.Check my eligibility
What is being tested?
The study is looking at how prednisone affects sperm count and quality after a man has his vasectomy reversed. It also aims to see if prednisone changes the chances of getting pregnant post-reversal. The effects will be studied across different ways of using prednisone.See study design
What are the potential side effects?
Possible side effects from taking prednisone may include mood swings, increased appetite leading to weight gain, trouble sleeping (insomnia), slower wound healing or infection due to immune suppression.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I am a man planning my first vasectomy reversal at the Male Fertility and Peyronie's Clinic.
Select...
My partner and I are trying to get pregnant now.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assess adverse events with prednisone utilization
Secondary outcome measures
Impact of Prednisone on semen concentration post vasectomy reversal
Impact of prednisone on pregnancy rates post vasectomy reversal.

Side effects data

From 2016 Phase 3 trial β€’ 854 Patients β€’ NCT00003389
98%
Anemia
93%
Leukocytes decreased
90%
Lymphopenia
84%
Neutrophils decreased
78%
Neuropathy-sensory
75%
Alopecia
74%
Fatigue
67%
Nausea
60%
Hyperglycemia
52%
Constipation
46%
Hypoalbuminemia
40%
Myalgia
34%
Stomatitis
33%
Insomnia
32%
Vomiting
27%
Platelets decreased
26%
Alkaline phosphatase increased
26%
Aspartate aminotransferase increased
23%
Dyspnea
20%
Dyspepsia
19%
Dysphagia
19%
Headache
16%
Anorexia
16%
Arthralgia
15%
Neuropathy-motor
15%
Abdominal pain
14%
Infection w/o neutropenia
14%
Cough
14%
Fever
13%
Rash/desquamation
13%
Diarrhea w/o prior colostomy
12%
Bone pain
11%
Weight gain
11%
Taste disturbance
11%
Anxiety/agitation
10%
Sweating
10%
Radiation dermatitis
9%
Rigors/chills
9%
Dizziness/lightheadedness
9%
Injection site reaction
8%
Hypoglycemia
8%
Dysphagia-esophageal radiation
8%
Blood bilirubin increased
8%
Chest pain
8%
Pain-other
8%
Phlebitis
7%
Creatinine increased
7%
Edema
7%
Pruritus
6%
Hot flashes
6%
Infection w/ grade 3 or 4 neutropenia
6%
Weight loss
5%
Muscle weakness
5%
Depression
5%
Mouth dryness
4%
Transfusion: pRBCs
4%
Pneumonitis/pulmonary infiltrates
3%
Thrombosis/embolism
3%
Febrile neutropenia
3%
Irregular menses
3%
Nail changes
2%
Allergic rhinitis
1%
Allergic reaction
1%
Infection w/ unknown ANC
1%
Syncope
1%
Sinus tachycardia
1%
Dehydration
1%
Neuropathic pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm B (Stanford V)
Arm A (ABVD)

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Prednisone Monthly - ScheduledExperimental Treatment1 Intervention
Group 2 will receive 3, one-month courses of prednisone (20 mg daily x 1 week, 10 mg daily x 1 week, 5 mg x 2 weeks). These will be given at the beginning of months 0, 2, and 4 and will be self-administered.
Group II: Prednisone Monthly - As NeededExperimental Treatment1 Intervention
Group 3 will receive a maximum of 3, one-month courses of prednisone (20 mg daily x 1 week, 10 mg daily x 1 week, 5 mg x 2 weeks). These will be administered based on sequential semen analyses. If a semen analysis demonstrates a drop in concentration from a prior analysis or if it shows a 0 concentration, the course will be administered.
Group III: Prednisone Every Other WeekExperimental Treatment1 Intervention
Group 4 will receive alternating 1 week dosages of prednisone (1 week on, 1 week off - 5 mg daily only) for a total of 24 weeks
Group IV: ControlActive Control1 Intervention
Group 1 will represent controls and will not receive prednisone in the 3-year post-op period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prednisone
2014
Completed Phase 4
~2370

Find a Location

Who is running the clinical trial?

Charitable Union for the Research and Education of Peyronie's DiseaseLead Sponsor
3 Previous Clinical Trials
280 Total Patients Enrolled
Benjamin GreenStudy DirectorThe Male Fertility and Peyronie's Clinic

Media Library

Prednisone Clinical Trial Eligibility Overview. Trial Name: NCT04788823 β€” Phase 4
Prednisone 2023 Treatment Timeline for Medical Study. Trial Name: NCT04788823 β€” Phase 4
Vasectomy Reversal Research Study Groups: Control, Prednisone Every Other Week, Prednisone Monthly - As Needed, Prednisone Monthly - Scheduled
Vasectomy Reversal Clinical Trial 2023: Prednisone Highlights & Side Effects. Trial Name: NCT04788823 β€” Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What earlier researches have been conducted with respect to Prednisone?

"Currently, 334 clinical trials exploring Prednisone are underway with 92 in the final phase. The majority of these experiments occur at a single site in Duarte, California; however, 16404 locations have participated in researching this compound."

Answered by AI

Does this program currently have openings for participants?

"Clinicaltrials.gov reveals that this medical investigation is still seeking participants. It was initially posted on February 24th 2021 and had its most recent update nearly one year later, on July 19th 2022."

Answered by AI

What are the criteria for individuals to become part of this medical experiment?

"This clinical trial is welcoming up to 100 participants who have had a vasectomy reversal and are in the age range of 18-65."

Answered by AI

What is the capacity of this clinical trial in terms of participants?

"Affirmative. Clinicaltrials.gov reveals that this trial, initially posted on February 24th 2021, is still open to participants. 100 individuals will be recruited from 1 location for the experiment's duration."

Answered by AI

Is this research program actively seeking participants above the age of fifty?

"This research is seeking adult individuals between the age of majority and 65 years old."

Answered by AI

What potential side effects should patients be aware of before taking Prednisone?

"The safety of Prednisone has been validated through a Phase 4 trial, thus it is granted the highest score of 3."

Answered by AI

What conditions can Prednisone be employed to alleviate?

"Prednisone is regularly prescribed to treat thyroiditis, but it can also be used in conjunction with other treatments for malignant neoplasms, ulcerative colitis and varicella-zoster virus acute retinal necrosis."

Answered by AI
~36 spots leftby Feb 2026